Oncobit Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.43M
- Investors
-
8
Oncobit General Information
Description
Developer of precision diagnostic and monitoring assays designed for personalized cancer care. The company's technology uses digital polymerase chain reaction, circulating tumor DNA analysis, targeted mutation hotspot detection, cloud-based analytics pipelines, liquid biopsy diagnostics, quantitative cancer marker detection, standardized reporting software, and non-invasive monitoring, enabling physicians to monitor disease progression and treatment response.
Contact Information
Website
www.oncobit.comCorporate Office
- Rütistrasse 16
- 8952 Schlieren
- Switzerland
Corporate Office
- Rütistrasse 16
- 8952 Schlieren
- Switzerland
Oncobit Timeline
Oncobit Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 30-Oct-2025 | $2.43M | Completed | Generating Revenue | ||
| 13. Later Stage VC (Series A) | 19-Nov-2024 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 12-Nov-2024 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 30-Apr-2024 | Completed | Startup | |||
| 10. Early Stage VC | 12-Jan-2022 | Completed | Startup | |||
| 9. Seed Round | 31-Dec-2021 | Completed | Startup | |||
| 8. Debt - General | 01-Nov-2021 | Completed | Startup | |||
| 7. Seed Round | 23-Jun-2021 | Completed | Startup | |||
| 6. Seed Round | 29-Apr-2021 | $2.52M | $2.62M | Completed | Startup | |
| 5. Accelerator/Incubator | 01-Jan-2021 | $100K | Completed | Startup |
Oncobit Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Pre-series A | ||||||||
| Seed Extension | ||||||||
| Seed Extension | ||||||||
| Seed Extension | ||||||||
| Seed preferred | ||||||||
| Seed preferred | ||||||||
| Ordinary | 4,554 | $1.254329 | $27.54 | $27.54 | 1x | $27.54 | 1.69% | |
| Ordinary | 784 | $1.254329 | $43.9 | $43.9 | 1x | $43.9 | 0.29% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Oncobit Comparisons
Industry
Financing
Details
Oncobit Competitors (3)
One of Oncobit’s 3 competitors is EntroGen, a Venture Capital-Backed company based in Los Angeles, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| EntroGen | Venture Capital-Backed | Los Angeles, CA | ||||
| Natera | Formerly VC-backed | Austin, TX | ||||
| Personalis | Formerly VC-backed | Fremont, CA |
Oncobit Patents
Oncobit Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4594527-A1 | Detection method, computer program product, data processing unit and detection system for detecting mutations of a polynucleotide in a biological sample | Pending | 28-Sep-2022 | ||
| US-20260185149-A1 | Detection method, computer program product, data processing unit and detection system for detecting mutations of a polynucleotide in a biological sample | Pending | 28-Sep-2022 | ||
| WO-2024068399-A1 | Detection method, computer program product, data processing unit and detection system for detecting mutations of a polynucleotide in a biological sample | Inactive | 28-Sep-2022 | C12Q1/6851 |
Oncobit Signals
Oncobit Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ID Solutions (France) | Corporation | Minority | ||
| Kickfund | Venture Capital | Minority | ||
| Avanteca Partners | Other | Minority | ||
| GF Group Holding | Corporation | Minority | ||
| Angel (individual) | Minority |
Oncobit FAQs
-
When was Oncobit founded?
Oncobit was founded in 2018.
-
Where is Oncobit headquartered?
Oncobit is headquartered in Schlieren, Switzerland.
-
What is the size of Oncobit?
Oncobit has 10 total employees.
-
What industry is Oncobit in?
Oncobit’s primary industry is Outcome Management (Healthcare).
-
Is Oncobit a private or public company?
Oncobit is a Private company.
-
What is the current valuation of Oncobit?
The current valuation of Oncobit is .
-
What is Oncobit’s current revenue?
The current revenue for Oncobit is .
-
How much funding has Oncobit raised over time?
Oncobit has raised $15M.
-
Who are Oncobit’s investors?
ID Solutions (France), Kickfund, Avanteca Partners, GF Group Holding, and are 5 of 8 investors who have invested in Oncobit.
-
Who are Oncobit’s competitors?
EntroGen, Natera, and Personalis are competitors of Oncobit.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process